Mycobacterium Tuberculosis
M. tuberculosis remains viable despite treatments for DNA extraction
Published in Medical Letter on the CDC and FDA, September 4th, 2005
"DNA fingerprinting of Mycobacterium tuberculosis by IS6110 restriction fragment length polymorphism analysis requires substantial high-quality DNA," investigators in Canada report.
"We demonstrated that, despite extraction treatments that might be expected to inactivate this organism, M. tuberculosis remained viable during this process," wrote W. Somerville and colleagues at Montreal General Hospital.
The authors concluded, "These data suggest that the extraction of M. tuberculosis DNA should be performed within...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Blood Safety
Epidemiology and characteristics of SEN virus described - Infection Control
Hand washing lowers risk of diarrhea and respiratory tract infections - Neuroscience
Behavioral test methods workshop conducted - Nosocomial Infection
Assessment of injection practices in Cambodia reported - Occupational Health
Silicosis risk in tin and tungsten miners and pottery workers reported - Ankylosing Spondylitis
U.S. FDA approves new use for Celebrex - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
